TNF-alpha and doxorubicin in hyperthermic perfusion for limb sarcomas (original) (raw)
Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and Efficient
Sylvie Bonvalot, Françoise Rimareix
Annals of Surgical Oncology, 2009
View PDFchevron_right
Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience
Luca Giovanni Campana
International Journal of Hyperthermia, 2015
View PDFchevron_right
Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor
Ineke Molenaar
Annals of Surgical Oncology, 1997
View PDFchevron_right
Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma
Mordechai Gutman
European Journal of Surgical Oncology (EJSO), 2009
View PDFchevron_right
Technology Insight: utility of TNF-α-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities
J. de Wilt
Nature Clinical Practice Oncology, 2006
View PDFchevron_right
The role of hyperthermic perfusion as a first step in the treatment of soft tissue sarcoma of the extremities
Renato Cavaliere
World Journal of Surgery, 1988
View PDFchevron_right
Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF- be better?
Nathalie Lassau, Axel Le Cesne
Annals of Oncology, 2005
View PDFchevron_right
Hyperthermic isolated limb perfusion with cisplatin in four patients with sarcomas of soft tissue and bone
Wolter Oosterhuis
European Journal of Surgical Oncology (EJSO), 1996
View PDFchevron_right
Isolated Limb Perfusions With Tumor Necrosis Factor and Melphalan for Locally Recurrent Soft Tissue Sarcoma in Previously Irradiated Limbs
J. de Wilt
Annals of Surgical Oncology, 2005
View PDFchevron_right
Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma
Alexander Eggermont
2007
View PDFchevron_right
Liposomal Doxorubicin with and without TNFα in the Perfusional Treatment of Advanced Soft Tissue Limb Sarcoma: Preliminary Results
Claudio Botti, Pasquale Perri
In vivo (Athens, Greece)
View PDFchevron_right
Fifty Tumor Necrosis Factor?Based Isolated Limb Perfusions for Limb Salvage in Patients Older Than 75 Years With Limb-Threatening Soft Tissue Sarcomas and Other Extremity Tumors
Alexander Eggermont
Annals of Surgical Oncology, 2003
View PDFchevron_right
Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities
Farhad Farzaliyev
2020
View PDFchevron_right
Preoperative Isolated Limb Infusion of Doxorubicin and External Irradiation for Limb-Threatening Soft Tissue Sarcomas
Mohamed Hegazy
Annals of Surgical Oncology, 2006
View PDFchevron_right
Different aspects of hyperthermic isolated limb perfusion
Robert van Ginkel
2002
View PDFchevron_right
Isolated Limb Perfusion in the Treatment of Advanced Soft-tissue Sarcomas
Martin Malawer
Musculoskeletal Cancer Surgery, 2004
View PDFchevron_right
Isolated limb perfusion for unresectable extremity sarcoma
Curtis Wray
Cancer, 2011
View PDFchevron_right
TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome
Robert van Ginkel
Journal of Surgical Oncology, 2011
View PDFchevron_right
Isolated limb perfusion with hyperthermia and chemotherapy: predictive factors for regional toxicity
Fernanda Oliveira
Clinics (São Paulo, Brazil), 2012
View PDFchevron_right
Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents
Corrado Angelini
Cancer Chemotherapy and Pharmacology, 2000
View PDFchevron_right
Limb salvage by neoadjuvant isolated perfusion with TNFα and melphalan for non-resectable soft tissue sarcoma of the extremities
François Mosimann
European Journal of Surgical Oncology, 2000
View PDFchevron_right
Isolated limb perfusion with tumour necrosis factor-α and melphalan for unresectable bone sarcomas of the lower extremity
Mordechai Gutman
European Journal of Surgical Oncology (EJSO), 1999
View PDFchevron_right
Advanced Extremity Soft Tissue Sarcoma: Prognostic Effect of Isolated Limb Perfusion in a Series of 88 Patients Treated at a Single Institution
Mario Santinami
Annals of Surgical Oncology, 2007
View PDFchevron_right
Treatment of Recurrent Sarcoma of the Extremities by Isolated Limb Perfusion Using Tumor Necrosis Factor Alpha and Melphalan
Renato Manzi
Tumori Journal, 1996
View PDFchevron_right
Isolated limb perfusion with tumor necrosis factor and melphalan for non‐resectable soft tissue sarcomas: Long‐term results on efficacy and limb salvage in a selected …
Robert van Ginkel
Journal of surgical …, 2008
View PDFchevron_right
Hyperthermia as an adjunctive treatment for soft-tissue sarcoma
Elisabetta Pennacchioli
Expert Review of Anticancer Therapy, 2009
View PDFchevron_right
Long-term Results of Hyperthermic, Isolated Limb Perfusion for Melanoma
Peter Kam
Annals of Surgery, 2007
View PDFchevron_right
Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma
M. Whitacre
Cancer, 1984
View PDFchevron_right
Toxicity and morbility after isolated lower limb perfusion in 242 chemo-hyperthermal treatments for cutaneous melanoma. The experience of the Tuscan Reference Centre
Erminia Mascitelli
Journal of Experimental & Clinical Cancer Research, 2008
View PDFchevron_right